Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With Gemcitabine
Clinical trial NCT00923299 · COMPLETED
Trial details
- NCT number
- NCT00923299
- Sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2010-04-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.